ABSTRACT
Epidemiology and pharmacoepidemiology research are critical for informing public health policy and practice and improving health outcomes. However, conducting high-quality research in many developing countries can be challenging due to limited funding, limited access to high-quality data sources, inadequate infrastructure, and ethical considerations. Increasing funding, strengthening data systems, building local capacity, addressing ethical considerations, and collaborating between different stakeholders. Limited availability of research tools and resources, limited research culture, political instability, limited access to healthcare, and language barriers. Addressing these challenges and issues is critical for improving the quality and impact of epidemiology and pharmacoepidemiology research in developing countries, contributing to improved public health outcomes and better health equity. This chapter aims to describe the patient safety research issues related to the epidemiology and pharmacoepidemiology, importance, facilitators, barriers, challenges and recommendations for the best practice in developing countries
